Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label, Multi-centre, Post-marketing Registry on the Use of ChondroMimetic for the Repair of Osteochondral Defects

NCT01209390 is registered in ClinicalTrials.gov with TiGenix n.v. as lead sponsor.

NCT NCT01209390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01209390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label, Multi-centre, Post-marketing Registry on the Use of ChondroMimetic for the Repair of Osteochondral Defects
Lead sponsor
TiGenix n.v.
Phase
Observational
Overall status
Terminated
Start date
September 30, 2010
Completion date
April 30, 2016
Enrollment
8 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteochondral defects